Use of Lidocaine in Endoscopic Submucosal Dissection

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

November 30, 2015

Conditions
Gastric Neoplasm
Interventions
DRUG

Lidocaine 1%

"Intravenous administration as bolus of lidocaine 1.5 mg/kg before sedation and infusion of lidocaine 2 mg/kg/hr during sedation.~Sedation with fentanyl and propofol"

DRUG

Normal saline

"Intravenous administration as bolus of normal saline 0.15 mL/kg before sedation and infusion of normal saline 0.2 mL/kg/hr during sedation.~Sedation with fentanyl and propofol"

Trial Locations (1)

Unknown

Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Severance Hospital, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Severance Hospital

OTHER

NCT02543411 - Use of Lidocaine in Endoscopic Submucosal Dissection | Biotech Hunter | Biotech Hunter